We would like to inform you that the application for the phase 2 clinical trial plan of NV01-A02 submitted to the Ministry of Food and Drug Safety has been approved as of July 15, 2024.

After the clinical trial plan is approved, the clinical trial will be prepared in accordance with the procedures set by law to protect the rights of the subjects, and from December this year at the latest, we plan to recruit subjects at 7 institutional hospitals, including Bundang Seoul National University Hospital. For families who wish to participate in the clinical trial, we would appreciate it if you could wait a little longer for the announcement of clinical participation at each hospital, even if it is uncomfortable.

We will do our best to inform you of the successful results of the NV01-A02 Phase 2 clinical trial as soon as possible.

Thank you.